Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals
Open Access
- 1 August 2005
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 45 (2) , 129-136
- https://doi.org/10.1016/j.femsim.2005.03.002
Abstract
We measured levels of six cytokines and human immunodeficiency virus (HIV) RNA in saliva from HIV-seropositive individuals and compared salivary cytokine levels in HIV-seropositives and seronegatives. All of the six tested cytokines were detected in saliva although interleukin-1β, interferon-γ and interleukin-10 were detected more frequently (90%, 68% and 61% of samples, respectively) than interleukin-6, tumor necrosis factor-α and tumor necrosis factor-α receptor II (2–17%). There was no significant association between cytokine levels in saliva and plasma suggesting that cytokines were produced locally. Interferon-γ levels were significantly higher in saliva from HIV-seropositives when compared to seronegatives while interleukin-10 levels were lower in seropositive saliva. Interleukin-10 levels were higher in individuals with low CD4 counts in the seropositive group. HIV RNA was detected in 29% of saliva samples from seropositives and there was a significant correlation between saliva and plasma HIV RNA levels. However, HIV RNA levels in saliva were not significantly associated with any of the saliva or plasma cytokine levels or with CD4 cell numbers. This study shows no association between inflammatory cytokine levels and HIV levels in saliva and suggests that saliva HIV levels are more influenced by blood HIV RNA levels than oral inflammation.Keywords
This publication has 28 references indexed in Scilit:
- Saliva and inhibition of HIV‐1 infection: molecular mechanismsOral Diseases, 2002
- Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulcerationAmerican Journal of Obstetrics and Gynecology, 2001
- Limits on oral transmission of HIV-1The Lancet, 2000
- Endogenous Mucosal Antiviral Factors of the Oral CavityThe Journal of Infectious Diseases, 1999
- Correlation of Human Immunodeficiency Virus Type 1 RNA Levels in Blood and the Female Genital TractThe Journal of Infectious Diseases, 1999
- Cervical Human Immunodeficiency Virus Type 1 Shedding Is Associated with Genital β‐Chemokine SecretionThe Journal of Infectious Diseases, 1998
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- In Vitro Inhibition of HIV-1 Infectivity by Human SalivasAIDS Research and Human Retroviruses, 1990
- Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and childrenThe Journal of the American Dental Association, 1989
- Isolation of HTLV-III Virus from Saliva in AIDSNew England Journal of Medicine, 1986